Sangamo Therapeutics(SGMOQ)
$0.11-0.00 (-3.64%)
SGMOQ
Sangamo Therapeutics Revenue
$0.11
At close:-0.00 (-3.64%)
Want to see SGMOQ full AI Analyst Report?
Sangamo Therapeutics (SGMOQ) Revenue
2,676 Followers
Sangamo Therapeutics Revenue
Sangamo Therapeutics had a revenue of 1.44M in the quarter ending Mar 31, 2026, with -89.87%. This bring the company's revenue in the last twelve months to 34.56M, Decreased 12.63%. In the fiscal year ending Dec 31, 2025, Sangamo Therapeutics had annual revenue of 39.55M with -31.57% growth.
- Revenue (ttm)
- 34.56M
- Revenue Growth
- -45.80%
- P/S Ratio
- 1.15
- Revenue/Employee
- $278,535
- Employees
- 142
- Market Cap
- $45.57M
Revenue Chart
Sangamo Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 39.55M | -18.25M | -31.57% |
| Dec 31, 2024 | 57.80M | -118.43M | -67.20% |
| Dec 31, 2023 | 176.23M | 64.93M | 58.34% |
| Dec 31, 2022 | 111.30M | 598.00K | 0.54% |
| Dec 31, 2021 | 110.70M | -7.49M | -6.34% |
| Dec 31, 2020 | 118.19M | 15.76M | 15.39% |
| Dec 31, 2019 | 102.43M | 17.98M | 21.29% |
| Dec 31, 2018 | 84.45M | 47.88M | 130.95% |
| Dec 31, 2017 | 36.57M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.